Wilsons analyst Melissa Benson maintained a Buy rating on Mayne Pharma Group Limited (MAYNF – Research Report) on August 12 and set a price target of A$0.61. The company’s shares closed today at $0.24.
Benson covers the Healthcare sector, focusing on stocks such as Mayne Pharma Group Limited, Pro Medicus Limited, and Immutep Ltd. According to TipRanks, Benson has an average return of -3.1% and a 41.67% success rate on recommended stocks.
In addition to Wilsons, Mayne Pharma Group Limited also received a Buy from Canaccord Genuity’s Martyn Jacobs in a report issued on August 8. However, on August 9, Citigroup maintained a Hold rating on Mayne Pharma Group Limited (Other OTC: MAYNF).
See Insiders’ Hot Stocks on TipRanks >>
The company has a one-year high of $0.27 and a one-year low of $0.15. Currently, Mayne Pharma Group Limited has an average volume of 16.23K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Mayne Pharma Group Ltd. engages in the development and manufacture of proprietary and generic products. It operates through the following segments: Generic Products, Specialty Brands, Metrics Contract Services, and Mayne Pharma International. The Generic Products segment involves in the manufacture and distribution of generic and branded pharmaceutical products. The Metrics Contract Services segment provides contract pharmaceutical services. The Specialty brands segments includes the distribution of branded pharmaceutical products. The Mayne Pharma International segment offers manufacturing and selling of branded and generic pharmaceutical products and provides contract manufacturing services to third party customers within Australia. The company was founded in 1845 and is headquartered in Salisbury, Australia.
Read More on MAYNF:
- CHICAGO RIVET & MACHINE CO. DECLARES DIVIDEND
- Riot Reports Second Quarter 2022 Financial Results, Current Operational and Financial Highlights
- J.P. Morgan Says the Stock Market Is Poised for More Upside; Here Are 2 Stocks the Banking Giant Likes
- Life360 reports Q2 and Half Year 2022 results
- THE VERY GOOD FOOD COMPANY REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
